Projects per year
International and National Collaboration
Publications and projects within past five years.
Profiles
Rim Bouslama
- Department of Pathology - Doctoral Student
- Sanna Lehtonen research group
- Doctoral Programme in Biomedicine
Person: UH, Teaching and research personnel
Projects 2017 2019
- 1 Active
Publications 1998 2019
Metformin increases glucose uptake and acts renoprotectively by reducing SHIP2 activity
Polianskyte-Prause, Z., Tolvanen, T. A., Lindfors, S., Dumont, V., Van, M., Wang, H., Dash, S. N., Berg, M., Naams, J-B., Hautala, L. C., Nisen, H., Mirtti, T., Groop, P-H., Wähälä, K., Tienari, J. & Lehtonen, S., Feb 2019, In : FASEB Journal. 33, 2, p. 2858-2869 12 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Glucose Transporters in Diabetic Kidney Disease-Friends or Foes?
Wasik, A. A. & Lehtonen, S., 9 Apr 2018, In : Frontiers in Endocrinology. 9, 12 p., 155.Research output: Contribution to journal › Review Article › Scientific › peer-review
Open Access
File
Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosis
Saurus, P., Tolvanen, T. A., Lindfors, S., Kuusela, S., Holthofer, H., Lehtonen, E. & Lehtonen, S., 6 Sep 2017, In : Scientific Reports. 7, 14 p., 10731.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Metformin and the catalytic activity of SHIP2
Berg, M. E. A., Tolvanen, T. A., Polianskyte-Prause, Z., Lindfors, S. H., Wähälä, K. & Lehtonen, S. H., 27 Aug 2017, p. 125. 1 p.Research output: Conference materials › Poster › Research
PACSIN2 accelerates nephrin trafficking and is up-regulated in diabetic kidney disease
Dumont, V., Tolvanen, T. A., Kuusela, S., Wang, H., Nyman, T. A., Lindfors, S., Tienari, J., Nisén, H., Suetsugu, S., Plomann, M., Kawachi, H. & Lehtonen, S., Sep 2017, In : FASEB Journal. 31, 18 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open Access
File
Activities 1991 2019
Fimlab Laboratories pathology seminars, Fimlab Laboratoriot Oy, Tampere: 'Metformiini ja uudet insuliiniherkistäjät - suoja diabeettista munuaistautia vastaan?'
Sanna Lehtonen (Speaker)13 Feb 2019
Activity: Talk or presentation types › Oral presentation
Amr Elseragy's thesis supervisory board member
Sanna Lehtonen (Supervisor)2019 → …
Activity: Examination types › Member of doctoral thesis committee / follow-up group
The Paulo Foundation (External organisation)
Sanna Lehtonen (Board member)2019 → …
Activity: Membership types › Membership or other role in national/international committee, council, board
Evaluator, final examination/Amudhala Karthik, TRANSMED MSc programme (Event)
Sanna Lehtonen (Board member)11 Jun 2018
Activity: Membership types › Membership or other role in review committee
Invited speaker at the Model organisms Minisymposium, University of Tampere, Tampere, Finland: 'The small GTPase sept7b in zebrafish organogenesis'
Sanna Lehtonen (Speaker)19 Jan 2018
Activity: Talk or presentation types › Invited talk
Prizes
Best communication price, European Diabetic Nephropathy Study Group (EDNSG) meeting, Gentofte, Denmark
Sanna Lehtonen (Recipient), 22 May 2015
Prize: Prizes and awards
Press / Media
Short communication in Duodecim, section In press
21/12/2018
1 media contribution
Press/Media: Press / Media
Interview in Apteekkari, section Lääkeuutiset
15/12/2017
1 media contribution
Press/Media: Press / Media
Interview for web-based media, 'New defences against kidney disease in diabetes'
01/01/2015
1 media contribution
Press/Media: Press / Media